Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure: Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan)

Circulation

Volumn 90, Issue 5, 1994, Pages 2510-2518

  Teerlink, John R ^a   Löffler, Bernd Michael ^a   Hess, Patrick ^a   Maire, Jean Paul ^a   Clozel, Martine ^a   Clozel, Jean Paul ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

endothelin; endothelium; heart failure; myocardial infarction; vessels

Indexed keywords

BOSENTAN; CILAZAPRIL; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; ENDOTHELIUM; HEART FAILURE; HEART INFARCTION; HEMODYNAMIC MONITORING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0027998055     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.90.5.2510     Document Type: Article

References (46)

1. O'Brien RF, Robbins RJ, McMurtry IF. Endothelial cells in culture produce a vasoconstrictor substance. J Cell Physiol. 1987; 132:263-270.
2. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
3. Ando K, Hirata Y, Shichiri M, Emori T, Marumo F. Presence of immunoreactive endothelin in human plasma. FEBS Lett. 1989; 245:164-166.
4. Cernacek P, Stewart DJ. Immunoreactive endothelin in human plasma: marked elevations in patients in cardiogenic shock. Biochem Biophys Res Commun. 1989;161:562-567.
5. Qiu S, Theroux P, Marcil M, Solymoss BC. Plasma endothelin-1 levels in stable and unstable angina. Cardiology. 1993;82:12-19.
6. Toyo-oka T, Aizawa T, Suzuki N, Hirata Y, Miyauchi T, Shin WS, Yanagisawa M, Masaki T, Sugimoto T. Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation. 1991;83:476-483.
7. Miyauchi T, Yanagisawa M, Tomizawa T, Sugishita Y, Suzuki N, Fujino M, Ajisaka R, Goto K, Masaki T. Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet. 1989;2:53-54. Letter.
8. Salminen K, Tikkanen I, Saijonmaa O, Nieminen M, Fyhrquist F, Frick MH. Modulation of coronary tone in acute myocardial infarction by endothelin. Lancet. 1989;2:747. Letter.
9. Yasuda M, Kohno M, Tahara A, Itagane H, Toda I, Akioka K, Teragaki M, Oku H, Takeuchi K, Takeda T. Circulating immunoreactive endothelin in ischemic heart disease. Am Heart J. 1990; 119:801-806.
10. Miyauchi T, Sugishita Y, Yamaguchi I, Ajisaka R, Tomizawa T, Onizuka M, Matsuda M, Kono I, Yanagisawa M, Goto K. Plasma concentrations of endothelin-1 and endothelin-3 are altered differently in various pathophysiological conditions in humans. J Cardiovasc Pharmacol. 1991;17:S394-S397.
11. Stewart DJ, Kubac G, Costello KB, Cernacek P. Increased plasma endothelin-1 in the early hours of acute myocardial infarction. J Am Coll Cardiol. 1991;18:38-43.
12. Lechleitner P, Genser N, Mair J, Maier J, Artner-Dworzak E, Dienstl F, Puschendorf B. Endothelin-1 in patients with complicated and uncomplicated myocardial infarction. Clin Invest. 1992;70:1070-1072.
13. Lechleitner P, Genser N, Mair J, Maier J, Artner-Dworzak E, Dienstl F, Puschendorf B. Plasma immunoreactive endothelin in the acute and subacute phases of myocardial infarction in patients undergoing fibrinolysis. Clin Chem. 1993;39:955-959.
14. Nakamura M, Arakawa N, Yoshida H, Funakoshi T, Chiba M, Abe Y, Makita S, Aoki H, Hiramori K. Increased plasma endothelin concentrations in patients with acute heart failure after myocardial infarction. Jpn Circ J. 1993;57:371-378.
15. Tomoda H. Plasma endothelin-1 in acute myocardial infarction with heart failure. Am Heart J. 1993;125:667-672.
16. Hiroe M, Hirata Y, Fujita N, Umezawa S, Ito H, Tsujino M, Koike A, Nogami A, Takamoto T, Marumo F. Plasma endothelin-1 levels in idiopathic dilated cardiomyopathy. Am J Cardiol 1991;68: 1114-1115.
17. Cody RJ, Haas GJ, Binkley PF, Capers Q, Kelley R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation. 1992;85: 504-509.
18. Lerman A, Kubo SH, Tschumperlin LK, Burnett JC Jr. Plasma endothelin concentrations in humans with end-stage heart failure and after heart transplantation. J Am Coll Cardiol. 1992;20: 849-853. See comments.
19. McMurray JJ, Ray SG, Abdullah I, Dargie HJ, Morton JJ. Plasma endothelin in chronic heart failure. Circulation. 1992;85:1374-1379.
20. Rodeheffer RJ, Lerman A, Heublein DM, Burnett JC Jr. Increased plasma concentrations of endothelin in congestive heart failure in humans. Mayo Clin Proc. 1992;67:719-724.
21. Stewart DJ, Cernacek P, Costello KB, Rouleau JL. Elevated endothelin-1 in heart failure and loss of normal response to postural change. Circulation. 1992;85:510-517.
22. Cavero PG, Miller WL, Heublein DM, Margulies KB, Burnett J Jr. Endothelin in experimental congestive heart failure in the anesthetized dog. Am J Physiol. 1990;259:F312-317.
23. Margulies KB, Hildebrand FL Jr, Lerman A, Perrella MA, Burnett JC Jr. Increased endothelin in experimental heart failure. Circulation. 1990;82:2226-2230.
24. Gauquelin G, Thibault G, Garcia R. Renal glomerular endothelin receptors in rats with high-output heart failure. Regul Pept. 1991; 35:73-79.
25. Underwood RD, Aarhus LL, Heublein DM, Burnett JC Jr. Endothelin in thoracic inferior vena caval constriction model of heart failure. Am J Physiol. 1992;263:H951-H955.
26. Fu LX, Kirkeboen KA, Liang QM, Sjogren KG, Hjalmarson A, Ilebekk A. Free radical scavenging enzymes and G protein mediated receptor signalling systems in ischaemically preconditioned porcine myocardium. Cardiovasc Res. 1993;27:612-616.
27. Löffler BM, Roux S, Kalina B, Clozel M, Clozel JP. Influence of congestive heart failure on endothelin levels and receptors in rabbits. J Mol Cell Cardiol. 1993;25:407-416.
28. Clozel M, Breu V, Burri K, Cassai JM, Fischli W, Gray GA, Hirth G, Löffler BM, Muller M, Neidhart W, Ramuz H. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature. 1993;365:759-761.
29. Selye H, Bajusz E, Grasso S, Mendell P. Simple techniques for the surgical occlusion of coronary vessels in the rat. Angiology, 1960; 11:398-407.
30. Löffler BM, Jacot-Guillarmod H, Maire JP. Concentrations and ratios of immunoreactive big-endothelin-1 and endothelin-1 in human, rat and rabbit plasma. Biochem Int. 1992;27:755-761.
31. Löffler B-M, Maire J-P. Radioimmunological determination of endothelin peptides in human plasma: a methodological approach. Endothelium. 1994;1:273-286.
32. Véniant M, Clozel JP, Hess P, Wolfgang R. Ro 40-5967, in contrast to diltiazem, does not reduce left ventricular contractility in rats with chronic myocardial infarction. J Cardiovasc Pharmacol. 1991;17:277-284.
33. Brockway BP, Mills PA, Azar SH. A new method for continuous chronic measurement and recording of blood pressure, heart rate and activity in the rat via radio-telemetry. Clin Exp Hypertens. 1991;A13:885-895.
34. Teerlink JR, Clozel JP. Hemodynamic variability and circadian rhythm in rats with heart failure: role of locomotor activity. Am J Physiol. 1993;264:H2111-H2118.
35. Natoff IL, Nixon JS, Francis RJ, Klevans LR, Brewster M, Budd J, Patel AT, Wenger J, Worth E. Biological properties of the angiotensin-converting enzyme inhibitor cilazapril. J Cardiovasc Pharmacol. 1985;7:569-580.
36. Teerlink JR, Goldhaber SZ, Pfeffer MA. An overview of contemporary etiologies of congestive heart failure. Am Heart J. 1991;121: 1852-1853.
37. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation. 1985;72:406-412.
38. Miyauchi T, Doi T, Suzuki N, Kakihana M, Yamaguchi I, Sugishita Y, Mitsui T, Hori M, Masaki T, Goto K. Plasma endothelin-1 concentrations in the coronary sinus in dogs with artificially induced myocardial infarction. Peptides. 1992;13:1013-1015.
39. Tomoda H. Coronary thrombolysis and endothelin-1 release. Angiology. 1993;44:441-446.
40. Watanabe T, Suzuki N, Shimamoto N, Fujino M, Imada A. Endothelin in myocardial infarction. Nature. 1990;344:114. Letter and comment.
41. Watanabe T, Suzuki N, Shimamoto N, Fujino M, Imada A. Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ Res. 1991;69:370-377.
42. Nambi P, Pullen M, Egan JW, Smith EF. Identification of cardiac endothelin binding sites in rats: downregulation of left atrial endothelin binding sites in response to myocardial infarction. Pharmacology. 1991;43:84-89.
43. Grieff M, Loertscher R, Shohaib SA, Stewart DJ. Cyclosporineinduced elevation in circulating endothelin-1 in patients with solid-organ transplants. Transplantation. 1993;56:880-884.
44. Cacoub P, Dorent R, Maistre G, Nataf P, Carayon A, Piette C, Godeau P, Cabrol C, Gandjbakhch I. Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndrome. Am J Cardiol. 1993;71:448-450.
45. Yoshibayashi M, Nishioka K, Nakao K, Saito Y, Matsumura M, Ueda T, Temma S, Shirakami G, Imura H, Mikawa H. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects: evidence for increased production of endothelin in pulmonary circulation. Circulation. 1991;84:2280-2285.
46. Pacher R, Bergler-Klein J, Globits S, Teufelsbauer H, Schuller M, Krauter A, Ogris E, Rodler S, Wutte M, Hartter E. Plasma big endothelin-1 concentrations in congestive heart failure patients with or without systemic hypertension. Am J Cardiol. 1993;71: 1293-1299.